Kaleido BioSciences Stock
Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.
About Kaleido BioSciences Stock
Tremendous new therapeutic opportunities are emerging from our rapidly expanding knowledge of the human microbiome. Kaleido is exploring this newfound territory through a unique discovery platform that develops novel chemistries targeted at specific microbiome functions. Our approach has produced clinically supported leads in multiple disease areas.
Funding History
| August 2015 | $4.5M |
|---|---|
| September 2017 | $60.0M |
| June 2018 | $101M |
Press
The Boston Globe - Jun, 25 2018
Business Wire - Mar, 26 2018
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Kaleido BioSciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
